This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: F23.8 (Other acute and transient psychotic disorders) | Special Copayment Reduction: V161 (severe intractable disease, 5 years) |
| B. Synonyms | - |
| C. Adult onset | Possible first manifestation in adulthood: very high — as with the F23 group as a whole, onset in early and middle adulthood is most common, and onset in adolescence or old age is also possible. |
| 1. History | Established in ICD-10 as a residual category for all acute and transient psychotic episodes not included in F23.0-F23.3; should be understood together with the history of the F23 group classification system. |
| 2. Causes | Etiology common to the F23 group (acute stress, vulnerability predisposition, neurobiological basis); a heterogeneous group in which it is difficult to specify a single cause; cause evaluation according to the individual clinical situation is needed. |
| 3. Genetics | Shares the genetic characteristics of the F23 group; as a heterogeneous category there is no single genetic profile; confirming the individual family history is clinically important. |
| 4. General epidemiology | A minority within the F23 group; includes diverse acute psychotic episodes that do not fit F23.0-F23.3; exact prevalence is difficult to estimate. |
| 5. Pathophysiology | Follows the mechanism common to the F23 group (dopamine hyperactivity, aberrant salience), but the mechanism varies with the clinical features of the included cases; functional psychosis mechanisms are applied after excluding organic causes. |
| 6. Symptoms | Various symptom combinations with acute-onset psychotic symptoms (delusions, hallucinations, disorganization) that do not meet the criteria of F23.0-F23.3; course shorter than 3 months. |
| 7. Signs | Clinical signs vary with the main symptom type of the included cases; acute-phase confusion, anxiety, and bizarre behavior; premorbid functioning level varies. |
| 8. Screening | Apply the evaluation methods common to the F23 group; exclusion of organic causes (brain disease, substances, medications) is essential; apply F23.8 after sequentially checking whether each category F23.0-F23.3 applies. |
| 9. Diagnosis | ICD-10 F23.8: acute onset (within 2 weeks), presence of psychotic symptoms, criteria for F23.0-F23.3 not met, exclusion of organic causes and of schizophrenia and mood disorders, shorter than 3 months; the nature of a diagnosis of exclusion. |
| 10. Treatment | Acute-phase symptom control (short-term antipsychotics), ensuring safety; thereafter individualized treatment according to cause and clinical features; consider the possibility of spontaneous remission. |
| 11. Prognosis | As a heterogeneous category, the prognosis also varies; generally follows the favorable prognostic characteristics of the F23 group; some progress to schizophrenia, mood disorders, or persistent delusional disorder. |
| 12. Prevention | Prevention strategies common to the F23 group (stress management, early detection, relapse prevention); follow-up to prevent chronicity; maintain opportunities to reassess the exact diagnosis. |
| 13. References | Castagnini A, Berrios GE. Acute and transient psychotic disorders: conceptual background and overview of research evidence. European Archives of Psychiatry and Clinical Neuroscience. 2009 … and 9 other papers |
Other acute and transient psychotic disorders (F23.8) is a residual category in the ICD-10 F23 group for classifying acute and transient psychotic episodes that fit none of F23.0 (acute polymorphic psychotic disorder without symptoms of schizophrenia), F23.1 (acute polymorphic psychotic disorder with symptoms of schizophrenia), F23.2 (acute schizophrenia-like psychotic disorder), and F23.3 (other acute predominantly delusional psychotic disorders).
Before 1992, when ICD-10 was introduced, there was no internationally unified classification system for acute and transient psychoses. In Europe, various concepts coexisted, such as reactive psychosis, cycloid psychosis, and acute psychotic episodes without poor prognosis. Through ICD-10, the WHO integrated these into the F23 group and subdivided it into F23.0-F23.3, while setting F23.8 for cases that fit none of these four categories.
The clinical situations included in F23.8 are diverse. For example, an acute onset in which delusions and hallucinations appear equally and the polymorphic criteria are not met and there are no symptoms of schizophrenia, or a case in which the main symptoms are predominantly hallucinations without clear delusions, or a psychotic presentation in the form of acute stupor, may correspond to F23.8. In ICD-11, acute and transient psychotic disorders (6A23) were integrated into a single category, and the previous detailed classification system was not retained.
Clinical conditions that may historically correspond to F23.8 include acute psychotic episodes with catatonic features, culture-bound acute psychoses (e.g., voodoo illness, koro), and acute psychosis accompanied by major somatic symptoms. These conditions do not fit exactly into a specific F23 subcode, but are functional acute psychotic episodes that are also distinct from organic psychosis (F06) and substance-induced psychosis (F1x.5).
F23.8 is a heterogeneous category, and the causes of the included clinical cases are also diverse. However, the etiological model common to the entire F23 group basically applies.
Stress-vulnerability model: As with the F23 group as a whole, the combination of biological vulnerability (neurodevelopmental predisposition, genetic vulnerability) and acute environmental stress is the main pathway leading to F23.8. Extreme acute stress (trauma, separation, job loss, sleep deprivation, etc.) triggers an acute psychotic episode on a vulnerable neurobiological background. In F23.8, the result of this combination does not converge on the specific clinical pictures of F23.0-F23.3 but shows a more mixed or atypical symptom profile.
Neurobiological basis: The aberrant salience mechanism due to dopamine hyperactivity also applies to F23.8. However, the diverse clinical conditions belonging to F23.8 may also be related to other neurotransmitter pathways such as the serotonin system and GABA-glutamate imbalance. In particular, when hallucinations are the main symptom, serotonin 2A receptor abnormalities may be involved.
Culture-related causes: Some F23.8 cases include acute psychotic episodes arising in a particular cultural context. Mixed dissociative-psychotic states associated with shamanism or religious rituals and acute psychosis associated with extreme religious experiences may fall into this. In such cases, cause evaluation that takes the cultural context into account is needed.
Borderline cases with physical illness: Some F23.8 cases may include borderline cases that have a minor physical precipitating factor (minor infection, minor endocrine abnormality) but in which a direct causal relationship to the degree of falling under the F06 category is not established. In such cases, precise cause evaluation through physical examination and laboratory testing is important for diagnostic classification.
There is no independent research on the genetics of F23.8; it is inferred indirectly from research on the genetic characteristics of the F23 group as a whole.
Heritability of the F23 group: Twin and family studies of acute and transient psychoses suggest moderate heritability. In studies using Scandinavian registry data, the concordance rate of monozygotic twins is higher than that of dizygotic twins, suggesting that genetic predisposition plays a partial role. However, heritability is lower than in schizophrenia (heritability about 80%), so the contribution of environmental factors is greater.
Diversity of genetic characteristics due to heterogeneity: Because F23.8 is a heterogeneous category, the genetic characteristics of the included cases are also diverse. If the included cases are actually early manifestations of schizophrenia or schizoaffective disorder, they will follow the genetic characteristics of those disorders, and if part of a mood disorder, those of mood disorders. The genetic characteristics differ depending on how the provisional diagnosis of F23.8 changes to the final diagnosis.
Vulnerability genes: Vulnerability genes shared with schizophrenia, bipolar disorder, and major depressive disorder (candidate genes such as DISC1, NRG1, and COMT; many SNPs identified in GWAS) may be relevant across the F23 group as a whole. There is clinical observation that the incidence of schizophrenia, schizoaffective disorder, bipolar disorder, and persistent delusional disorder is higher among first-degree relatives of F23.8 patients than in the general population.
Because F23.8 is a residual category of the F23 group, independent epidemiological data are very limited.
Incidence and prevalence: The incidence of the F23 group as a whole is estimated at 4-9 per 100,000 population per year. F23.8 is a residual category encompassing cases within the F23 group that do not fit F23.0-F23.3, and it is estimated to account for 10-20% of the F23 group as a whole, but this varies greatly between studies. After the transition to ICD-11, with integration into a single category, F23.8-specific epidemiological data are expected to decrease further.
Sex and age: The epidemiological characteristics of the F23 group as a whole (slight female predominance, onset mostly in early to middle adulthood) apply roughly to F23.8 as well, but there are many exceptions owing to the heterogeneous nature of the category. It is known to arise most often in early adulthood (ages 18-35) and middle adulthood (ages 35-50), but cases with onset in adolescence and old age may also be classified as F23.8.
Epidemiological context in Korea: Systematic epidemiological studies of acute psychotic episodes in Korea are lacking. Admission frequency for the F23 code group as a whole can be confirmed from Health Insurance Review & Assessment Service claims data, but separately analyzed data on F23.8-specific frequency are rare. Owing to the provisional nature of F23.8, some cases are reclassified in subsequent evaluation as schizophrenia (F20), bipolar disorder (F31), or schizotypal variants of brief psychotic disorder.
The pathophysiology of F23.8 follows the dopamine hyperactivity-aberrant salience pathway common to the F23 group, but the pathways involved may differ according to the diverse clinical features of the included cases.
Common mechanism: aberrant salience: Dopamine hyperactivity due to acute stress induces aberrant salience, producing psychotic symptoms such as delusions and hallucinations. This mechanism applies not only to F23.0-F23.3 but also to F23.8. In F23.8, the result of aberrant salience does not converge on a specific symptom type (polymorphic, delusion-predominant, schizophrenia-like) but appears in a mixed, atypical form.
Hallucination-predominant mechanism: In some F23.8 cases, hallucinations (especially auditory or visual) may be more prominent than delusions. In this case, besides dopamine, serotonin 2A receptor hyperactivity may be involved, and congenital or acquired differences in serotonin system sensitivity may determine the hallucination-predominant symptom profile.
Mechanism with catatonic features: Catatonia sometimes accompanies an acute psychotic episode, and this can be classified as F23.8. GABA-B receptor dysfunction and basal ganglia-thalamo-cortical circuit dysfunction are involved in the development of catatonia. An acute psychotic episode with catatonia can also be described in brief psychotic disorder (DSM-5) using the catatonia specifier.
Recovery mechanism: The rapid recovery characteristic of the F23 group as a whole also applies to F23.8. Acute psychotic symptoms can disappear quickly with stress relief, restored sleep, and a safe environment alone. Antipsychotics block dopamine hyperactivity, reduce aberrant salience, and accelerate symptom recovery.
The symptoms of F23.8 are, by definition, various combinations of acute psychotic symptoms that do not meet the specific criteria of F23.0-F23.3.
Mixed psychotic symptoms: Cases corresponding to F23.8 may include those in which delusions and hallucinations appear in equal proportion, mood symptoms (extreme anxiety, ecstasy) are indistinctly mixed with psychotic symptoms, or there is some symptom fluctuation although the polymorphic criteria are not fully met. This mixed picture makes clear classification into a specific subcode difficult.
Hallucination-predominant type: In some cases, auditory or visual hallucinations are the main symptoms, and there are no clear delusions or only incomplete delusions formed secondarily around the hallucinations. This does not fit F23.3 (delusion-predominant) or F23.0/F23.1 (polymorphic), and is therefore classified as F23.8.
Type with catatonic features: Acute-onset catatonia (stupor, negativism, waxy flexibility, stereotypy, excitement) sometimes accompanies psychotic symptoms. Such an acute psychotic episode with catatonia may not clearly fit any of F23.0-F23.3 and thus corresponds to F23.8. Clinical recognition is important because episodes with catatonia show a specific response to benzodiazepines.
Course: As with the F23 group as a whole, the entire episode must be shorter than 3 months. If it lasts 3 months or more, maintaining F23.8 is inappropriate, and conversion to another diagnosis (schizophrenia, schizoaffective disorder, mood disorder, persistent delusional disorder) should be considered through reassessment.
The clinical signs of F23.8 patients appear broadly according to the diverse symptom types of the included cases.
Common acute-phase signs: The acute-phase signs common to the F23 group appear. Sudden behavior change, confused or bizarre speech, increased suspicion and wariness, sleep disturbance, and food refusal are the first signs observed by family or those around the patient. Agitation and excitement may accompany, and in some cases there is a risk of harm to self or others.
Signs of the hallucination-predominant type: Behavior such as talking, laughing, or crying alone in a private room in response to auditory hallucinations, or startled or avoidant behavior in response to visual hallucinations, is observed. Hyperacusis or a sudden defensive attitude may appear.
Signs of the type with catatonic features: When catatonia is present, sudden motor inhibition (stupor, negativism) or motor excess (excitement, stereotyped movements) appears. Waxy flexibility (maintaining a posture into which the limbs are gently placed), echolalia, and echopraxia may be observed. When these signs appear at acute onset, immediate medical evaluation and catatonia treatment (lorazepam, etc.) should be considered.
Premorbid functioning: Because of the characteristics of the F23 group as a whole, premorbid functioning is often relatively good, which helps in differentiation from schizophrenia (F20). However, F23.8 is a heterogeneous category, so in some cases there may be evidence of premorbid functional decline, and in such cases the possibility of a first episode of schizophrenia should be considered more actively.
Screening for an acute psychotic episode suspected to be F23.8 includes exclusion of organic causes and evaluation for subclassification within the F23 group.
Exclusion of organic causes: The first thing to exclude in an acute psychotic episode is an organic cause. Laboratory tests and physical examination are essential to exclude systemic infection (fever, infection markers), head trauma, epilepsy (postictal state), metabolic abnormalities (hypoglycemia, thyroid dysfunction, electrolyte abnormalities), and psychosis induced by substances (amphetamine, cocaine, cannabis, hallucinogens) and medications (steroids, anticholinergics).
Structured mental health assessment: Symptom type and severity are assessed with standardized tools such as the BPRS (Brief Psychiatric Rating Scale) and PANSS (Positive and Negative Syndrome Scale). In particular, the relative weight of delusions, hallucinations, disorganization, and catatonia symptoms is assessed, and whether the criteria of each of F23.0-F23.3 are met is checked sequentially.
Process of confirming F23 subclassification: Before applying F23.8, the process of sequentially checking the criteria of F23.0 (polymorphic + no Schneiderian first-rank symptoms), F23.1 (polymorphic + Schneiderian first-rank symptoms present), F23.2 (meets schizophrenia criterion A but duration short), and F23.3 (delusion-predominant + no polymorphism) is essential to secure the justification for a diagnosis of F23.8. F23.8 is used when, after this process is completed, it is confirmed that none applies.
The diagnosis of F23.8 has the nature of a residual diagnosis made through a process of exclusion.
ICD-10 F23.8 diagnostic criteria: (1) acute onset (peak reached within 2 weeks), (2) presence of psychotic symptoms (delusions, hallucinations, disorganized thinking, or catatonia), (3) not corresponding to any of F23.0-F23.3, (4) exclusion of organic mental disorders (F00-F09) and substance-induced mental disorders (F1x.5), (5) criteria for schizophrenia (F20) and mood disorders (F30-F39) not met, (6) the entire episode shorter than 3 months. F23.8 is applied when all six conditions are met.
Corresponding DSM-5 diagnosis: There is no diagnostic category in DSM-5 that directly corresponds to F23.8. Brief Psychotic Disorder (298.8) in DSM-5 is the most similar, and the catatonia specifier or the with marked stressor specifier can be used in particular. DSM-5 bases its criteria on duration (less than 1 month) rather than symptom type, so F23.8 cases with a symptom duration of less than 1 month are classified as DSM-5 brief psychotic disorder.
Change in ICD-11: In ICD-11 (2022), the F23 group was unified as acute and transient psychotic disorder (6A23), and the subclassification by symptom type (polymorphic, delusion-predominant, schizophrenia-like) disappeared. Therefore, F23.8 does not exist separately in ICD-11, and the corresponding cases are classified under the single code 6A23 or 6A2Z (unspecified). On transition from ICD-10 to ICD-11, F23.8 cases need to be reclassified.
Treatment of F23.8 centers on acute-phase stabilization and symptom control common to the F23 group as a whole, individualized according to the clinical features of the included cases.
Acute-phase drug treatment: Second-generation antipsychotics (risperidone, olanzapine, aripiprazole, quetiapine, etc.) are the first choice for acute-phase symptom control. When the patient refuses oral administration or has severe acute excitement, an intramuscular formulation can be used. Owing to the characteristics of the F23 group, effects are often seen at relatively low doses, and excessive medication only increases the risk of adverse effects. When catatonia accompanies, lorazepam is recommended as first-line treatment, and caution is needed because using an antipsychotic alone may rather worsen catatonia.
Non-drug treatment: In the acute phase, providing a safe, low-stimulation environment, supportive conversation, and family education are important. After the acute phase, supportive psychotherapy, cognitive behavioral therapy (CBT), and stress management education help prevent relapse. It also includes strengthening social support systems and support for return to work or school.
Duration of treatment: Owing to the short course characteristic of the F23 group, the optimal duration of antipsychotic maintenance treatment has not been established. Maintenance treatment for 1-3 months after complete resolution of symptoms is generally recommended, but it is decided individually in consideration of the possibility of relapse. If symptoms persist for 3 months or more, diagnostic reassessment including long-term maintenance treatment is needed.
The prognosis of F23.8 varies owing to the heterogeneous nature of the category, but the relatively favorable prognostic characteristics of the F23 group as a whole basically apply.
Short-term prognosis: In studies of the F23 group as a whole, about 70-80% of patients achieve good functional recovery within 1-2 years after the first episode. F23.8 is also included in this category, but owing to its heterogeneous nature, the long-term course may be poor in some cases. The prognosis is better with early treatment initiation, good premorbid functioning, and a clear stress precipitant.
Long-term diagnostic change: In a considerable proportion of patients initially diagnosed with F23.8, the final diagnosis changes during follow-up. A meta-analysis reported that about one third of patients admitted with acute psychosis are reclassified as schizophrenia or schizoaffective disorder within 2-5 years. Reclassification to a mood disorder (bipolar disorder, major depressive disorder) is also not uncommon.
Poor prognostic factors: Premorbid functional decline, a strong family history of schizophrenia spectrum disorders, treatment started after a long period of illness (prolonged DUP), male sex, and low social support are associated with a poor prognosis. When these factors are present, active follow-up and immediate treatment intervention at relapse are important.
Prevention of F23.8 follows the general acute psychosis prevention strategy for the F23 group as a whole.
Primary prevention: Stress management education and strengthened crisis intervention services to prevent acute stress reactions are important. In particular, improving access to mental health support for immigrants, people with experiences of social exclusion, and groups exposed to extreme occupational stress contributes to preventing onset. It also includes sleep hygiene education.
Secondary prevention (early detection): It is important to build a service system that allows early access to specialist mental health services when acute-onset psychotic symptoms are present. Education of general practitioners and emergency department staff in early recognition of acute psychosis, and building rapid referral pathways from primary care to mental health services, contribute to shortening the DUP (duration of untreated psychosis).
Tertiary prevention (relapse prevention): Preventing relapse after the first episode is the most important prevention task in the F23 group. It includes education on medication adherence, education on relapse warning signs (psychotic prodromal symptoms), and establishing an early crisis response plan. Through continuous follow-up, the treatment strategy is adjusted appropriately if the diagnosis changes. Family education and support play an important role in preventing relapse.